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Abstract Membrane transporters of the RND superfamily confer multidrug resistance to 
pathogenic bacteria, and are essential for cholesterol metabolism and embryonic development in 
humans. We use high-resolution X-ray crystallography and computational methods to delineate the 
mechanism of the homotrimeric RND-type proton/drug antiporter AcrB, the active component of 
the major efflux system AcrAB-TolC in Escherichia coli, and one most complex and intriguing 
membrane transporters known to date. Analysis of wildtype AcrB and four functionally-inactive 
variants reveals an unprecedented mechanism that involves two remote alternating-access 
conformational cycles within each protomer, namely one for protons in the transmembrane region 
and another for drugs in the periplasmic domain, 50 Å apart. Each of these cycles entails two 
distinct types of collective motions of two structural repeats, coupled by flanking α-helices that 
project from the membrane. Moreover, we rationalize how the cross-talk among protomers across 
the trimerization interface might lead to a more kinetically efficient efflux system.
DOI: 10.7554/eLife.03145.001
Introduction
The AcrA-AcrB-TolC complex is a secondary active antiport system in Escherichia coli, powered by the 
electrochemical proton gradient across the inner membrane of this Gram-negative bacterium (Okusu 
et al., 1996). Its biological function is to capture cytotoxic compounds from either the periplasmic 
space or the inner membrane, and to expel them across the outer membrane, into the extracellular 
medium. This tripartite system is arguably one of the most complex and intriguing secondary trans-
porters known to date, from both structural and mechanistic standpoints. The AcrAB-TolC system and 
its homologues are also of considerable biomedical interest, as they confer multidrug resistance to 
important pathogenic bacteria involved in human disease (Nikaido and Pagès, 2012).
AcrB is the inner-membrane component of the system, and is responsible for both substrate recog-
nition and energy transduction. This membrane protein belongs to the resistance-nodulation-cell-
division (RND) family (Tseng et al., 1999), which also includes transporters involved in protein secretion 
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(e.g., SecDF of E. coli), export of lipids (e.g., MmpL7 of Mycobacterium tuberculosis) and pigment 
export (e.g., ORF4 of Xanthomonas oryzae). In humans, the RND transporters NPC1 and Patched play 
key roles in the regulation of cholesterol metabolism and in the Hedgehog signaling pathway of 
embryonic cells, respectively (Taipale et al., 2002; Scott and Ioannou, 2004).
The first known structure of AcrB, solved by X-ray crystallography at a resolution of 3.5 Å, revealed 
a homotrimeric assembly in which all protomers adopt the same conformation (Murakami et al., 
2002). In each protomer, the transmembrane (TM) domain consists of 12 α-helices (TM1–TM12), mostly 
interconnected by short unstructured loops as is common. In contrast to other secondary transporters, 
however, AcrB also features two large periplasmic insertions, between TM1 and TM2, and between 
TM7 and TM8, which account for approximately 60% of the 1049 amino acids in each protomer. These 
insertions are highly structured domains that project 70 Å away from the membrane, and form exten-
sive interfaces among protomers (Figure 1). The TM domains barely contribute to the trimer interface, 
in further contrast to typical homomeric transporters. The more distal region of the periplasmic domain 
features a central funnel-shaped cavity that channels the substrate towards TolC, the outer-membrane 
channel component (140 Å in length) of this transport system (Koronakis et al., 2000). AcrA, the third 
component, functions as a peripheral scaffold to mediate the interaction between AcrB and TolC 
(Akama et al., 2004; Mikolosko et al., 2006; Tikhonova et al., 2011; Du et al., 2014).
The intricate and unusual topology of AcrB and its trimerization state were confirmed by sub-
sequent higher-resolution X-ray structures obtained from crystals grown in different space groups, 
elife digest The interior of living cells is separated from their external environment by an 
enveloping membrane that serves as a protective barrier. To regulate the chemical composition of 
their interior, cells are equipped with specialized proteins in their membranes that move substances 
in and out of cells. Membrane proteins that expel molecules from the inside to the outside of the 
cell are called efflux pumps.
In Escherichia coli bacteria, an efflux pump known as AcrB is part of a system that removes toxic 
substances from the bacterial cell—such as the antibiotics used to treat bacterial infections. AcrB 
and other closely related efflux pumps in pathogenic bacteria are often polyspecific transporters—
they can transport a large number of different toxic molecules. These efflux pump systems are also 
more active in bacteria that have been targeted by antibiotics, and therefore they help bacteria to 
evolve resistance to multiple drugs. The emergence of bacterial multi-drug resistance is a global 
threat to human health; to combat this phenomenon, it is essential to understand its molecular basis.
Each AcrB protein has three main parts or domains. The periplasmic domain, which is located 
between the two membranes that surround E. coli, works via an ‘alternating-access cycle’; that is, 
the shape of the periplasmic domain changes between three different forms in such a way that 
antibiotic molecules are first captured and subsequently squeezed through the protein towards the 
outside of the cell. However, the mechanism of the transmembrane domain—which is embedded in 
the innermost membrane of the bacterium and is the source of energy for the transport process—
was not understood.
Here, Eicher et al. use X-ray crystallography to examine the three-dimensional structures of the 
AcrB efflux pump—and several inactive variants—in high detail. Combining these results with 
computer simulations reveals the mechanism used by the transmembrane domain to take up 
protons from the exterior and transport them into the cell. Proton transport also proceeds according 
to an alternating-access mechanism—and, although the transmembrane and periplasmic domains 
are far apart, their movements are tightly linked. Thus, because proton uptake releases energy, the 
transmembrane domain effectively powers the periplasmic domain to expel drugs and other 
molecules. Eicher et al. note that a similar mechanism has not been seen before in other efflux 
pumps or transporter proteins.
Understanding how AcrB works opens up new avenues that could be exploited to develop new 
drugs against multidrug resistant bacteria. Furthermore, Eicher et al. suggest that efflux pumps in 
humans closely related to AcrB might function in a similar way—including those required for 
regulation of cellular cholesterol, and for the correct development of embryos.
DOI: 10.7554/eLife.03145.002
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Figure 1. Topology and secondary structure representations of the AcrB protomers. (A) Topology of the AcrB 
protomers in the transmembrane (TM) and porter domains. Our analysis indicates that the TM domain consists of 
two 5-helix parallel repeats, referred to as R1 and R2, and two flanking helices, TM2 and TM8. R1 (blue) is connected 
to R2 (red) through helix Iα (white), which lies parallel to the cytoplasmic face of the membrane. The porter domain 
also consists of two repeats of two subdomains each, namely PC1 and PN2 (blue), and PN1 and PC2 (red). TM2 
(cyan) connects R1 to PN2, whereas TM8 (orange) links R2 to PC2. Other connections among porter sub-domains 
and R1/R2 are indicated by open/closed squares/circles. Hexagons indicate the connections between the porter 
domain and the funnel domain (FD), not drawn in this scheme. (B) Cartoon representation of the secondary 
structure of an AcrB protomer, in the context of the complete trimer. The other two protomers are drawn as a 
molecular surface (gray). Different sub-domains are colored as in (A), with inter-connecting loops and the FD 
shown in black.
DOI: 10.7554/eLife.03145.003
The following figure supplements are available for figure 1:
Figure supplement 1. Cartoon representation of the porter domain of AcrB in the asymmetric state, viewed from 
the outer membrane, along the perpendicular to the inner membrane. 
DOI: 10.7554/eLife.03145.004
Figure supplement 2. Molecular simulation systems employed in this study. 
DOI: 10.7554/eLife.03145.005
several of which include bound substrates (Murakami et al., 2006; Seeger et al., 2006; Sennhauser 
et al., 2007; Nakashima et al., 2011, 2013; Eicher et al., 2012). These structures, however, also 
revealed that upon substrate loading AcrB becomes asymmetric, that is, each protomer in the trimer 
adopts one of three distinct conformational states, designated as ‘loose’ (L), ‘tight’ (T) and ‘open’ (O), 
or alternatively, as ‘access’, ‘binding’ and ‘extrusion’, (Murakami et al., 2006; Seeger et al., 2006). 
On the basis of these structures as well as other findings (Seeger et al., 2008; Takatsuka and Nikaido, 
2009), it has also become generally accepted that drug recognition and efflux are mediated by a sub-
domain of the periplasmic region, referred to as the porter domain (Figure 1, Figure 1—figure sup-
plement 1), whose mechanism is akin to that of a peristaltic pump (Seeger et al., 2006). Specifically, 
recognition of high molecular-mass drugs occurs in the L state, via an access pocket in the porter 
domain that is open to the periplasmic space (Nakashima et al., 2011; Eicher et al., 2012). When the 
L protomer transitions to the T state, drugs translocate to a binding pocket deeper in the protein; 
low molecular-mass drugs, however, can apparently bind directly to the deep binding pocket in the 
T protomer without binding to the access pocket first (Nakashima et al., 2011). Drug extrusion occurs 
next, in the transition from T to O, which re-shapes and opens the binding pocket to a central cavity 
in the funnel domain, which leads to the lumen of the TolC channel. Finally, the O to L transition resets 
the conformational cycle by re-exposing the binding site to the periplasm. The extensive interface 
between protomers in the porter domain, and the asymmetric nature of the trimer, also suggest 
that the three protomers are conformationally coupled (Pos, 2009). Indeed, recent measurements of 
AcrB transport kinetics (Nagano and Nikaido, 2009; Lim and Nikaido, 2010) are consistent with a 
bi-site activation model (Pos, 2009), analogous to the binding-change mechanism of the ATP synthase 
(Boyer, 1997).
Biochemistry | Biophysics and structural biology
Eicher et al. eLife 2014;3:e03145. DOI: 10.7554/eLife.03145 4 of 26
Research article
The transport mechanism of the TM domain of AcrB, in contrast, remains largely undefined. The 
asymmetric trimer structures indicate that this domain also cycles between three distinct conforma-
tions, and point to several ionizable residues in its core (D407, D408, K940 and R971) that might 
function as a proton-relay network. Nevertheless, no clear interpretation of existing data has been 
formulated yet in terms of an alternating-access proton transport mechanism, which is a necessary 
condition for the transporter to harness the energy stored in the transmembrane electrochemical 
gradient. How this proton-motive-force is mechanically transduced to the porter domain, in order to 
power uphill drug efflux, also remains to be determined.
Here, we gain insights into these crucial mechanistic questions from a series of new crystal struc-
tures of AcrB, systematically analyzed with molecular simulations and other computational methods. 
More specifically, we examine the TM domain of the transporter in an improved atomic structure of 
wildtype AcrB (Eicher et al., 2012), at 1.9 Å resolution, and also report the structures of four single-
substitution variants (D407N, D408N, K940A and R971A), all of which are inactive both in proton 
translocation and drug efflux, solved at resolutions between 2.0 and 2.3 Å. Taken together with our 
computational analysis, these data enable us to delineate the alternating-access mechanism of proton 
transport of the TM domain, and rationalize how this mechanism energizes drug efflux, more than 
50 Å away.
Results and discussion
Modularity and collective motions in the periplasmic and 
transmembrane domains
Despite the unique topological complexity of AcrB, a systematic analysis of its structure permits to 
rationalize its conformational cycle in terms of collective motions of distinct structural units. In the 
porter domain, as noted previously, each protomer consists of two structural repeats, referred to as 
PN1/PC2, and PN2/PC1 (Figure 1, Figure 1—figure supplement 1). Each repeat is a tandem of two 
similar α/β sub-domains, joined by a shared β-strand. The PN1/PC2 repeat appears to be a rigid unit 
throughout the LTO conformational cycle. Analysis of the conformation of this repeat in the 1.9 
Å-resolution crystal structure of wildtype AcrB (Eicher et al., 2012) yields root-mean-square differ-
ences (RMSD) among states of less than 0.5 Å (Supplementary file 1). By contrast, the PN2/PC1 
tandem changes its conformation significantly, in particular in the L to T (RMSD ∼2.0 Å) and T to 
O transitions (RMSD ∼1.8 Å). This is due to the rearrangement of PN2 relative to PC1, rather than to 
changes in the internal structure of the individual α/β domains, which appear to be quite inflexible 
across the cycle, in both repeats (Supplementary file 1). As described elsewhere (Murakami et al., 
2006; Seeger et al., 2006; Sennhauser et al., 2007; Pos, 2009; Nakashima et al., 2013), the changes 
in PN2/PC1 reflect binding of the substrate deep within the hydrophobic core of the tandem, in the 
T state, and its subsequent release into the interior of the funnel domain, in the O state (Figure 1—
figure supplement 1; Video 1, Video 2, Video 3). Incidentally, the conformation of the funnel 
domain is largely unchanged throughout the cycle (RMSD < 0.5 Å).
Given the modular nature of the porter domain, we reasoned that the TM domain might also con-
sist of structural repeats, as is observed in other secondary transporters. To identify these, we quanti-
fied the degree of similarity of combinative structural superpositions of fragments of the transmembrane 
12-helix bundle in the L, T and O states (Figure 2). This analysis indicates that the conformational cycle 
of the TM domain entails relative motions of two structural repeats within each protomer, which had 
not been previously recognized. Each of these repeats, which we refer to as R1 and R2, comprise five 
transmembrane α−helices. The N-terminal repeat, R1, includes TM1 and TM3 to TM6, while the 
C-terminal repeat, R2, comprises TM7 and TM9 to TM12 (Figure 1). R1 and R2 are thus oriented in 
parallel, and are rotated relative to each other approximately 180° around an axis perpendicular to the 
membrane plane. Interestingly, each repeat is flanked by a single transmembrane helix that seems to 
function as a coupling element with the periplasmic porter domain (Figure 1). The flanking helices are 
TM2 and TM8, respectively; TM2 is linked to the flexible PN2/PC1 repeat in the porter domain, while 
TM8 is connected to the more rigid PN1/PC2 unit (Figure 1).
Analysis of R1, for example, shows that the structure of this five-helix bundle is largely preserved 
in the L, T and O conformations; the RMSD among these states ranges from 0.8 to 1.1 Å (Figure 2—
figure supplement 1). These differences are even smaller for R2, with RMSD values between 0.3 and 
1.0 Å (Figure 2—figure supplement 1). R1 and R2 are, however, always different from each other 
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(RMSD ∼3.5 Å). Further inspection also shows 
that R1 and R2 move relative to each other 
throughout the conformational cycle of each 
protomer (Figure 2—figure supplement 2). For 
example, if we superimpose R1 in the L and T 
conformations, the RMSD of the corresponding 
R2 repeats is 1.6 Å; for the T to O transition the 
analogous value is 2.1 Å, and for O to L, 3.1 Å. 
These relative differences are substantially larger 
than those observed individually within R1 or R2, 
for all steps of the cycle. Therefore, it is clear that 
R2 and R1 undergo collective motions during the 
LTO cycle that are larger in magnitude than the 
changes in their internal structure.
Structural overlays and interpolations of the 
L, T and O conformations, based on the topo-
logical decomposition just described, reveal the 
nature of the relative repeat motions within the 
TM domain during the transport cycle (Figure 3; 
Video 4, Video 5, Video 6). In the L to T transi-
tion, R1 and R2 undergo a rocking motion around 
an axis that is tilted relative to the membrane 
plane (Figure 3; Video 4). By contrast, in the tran-
sition between the T and O states, and between 
O and L, what can be observed is mostly a lateral 
shear motion of R1 and R2, relative to each other 
(Figure 3; Video 5, Video 6). This analysis also 
highlights the motions in the helices flanking the 
repeats, TM2 and TM8. In the L to T transition, 
TM2 moves downwards relative to R1 (toward the 
cytoplasm), returning to the up state in the O con-
formation (Figure 3; Video 4, Video 5, Video 6). 
By contrast, TM8 is similarly positioned in the L 
and T states, and largely unengaged from R2. 
However, during the T to O transition this α-helix 
becomes closely packed against R2, through 
hydrophobic interactions with TM5. In this tran-
sition TM8 also becomes elongated, reaching 
directly to the PN1/PC2 unit (Figure 3; Video 4, 
Video 5, Video 6).
Interestingly, the membrane domain features 
an additional helix, Iα, which lies parallel to the membrane, on the cytoplasmic side. This helix 
is inserted between TM6 and TM7 in the protein sequence, and thus links R1 and R2 (Figure 1). 
Structurally, however, Iα is mostly adjacent to R2, and interacts with R1 (via hydrophobic interactions 
and hydrogen-bonds) primarily at the cytoplasmic end of TM2, at a right angle (Figure 3; Video 4, 
Video 5, Video 6). Our analysis shows that Iα is effectively part of R2, and that it moves rigidly along 
with this repeat in the three conformational transitions, most probably in response to the motion 
of TM2 (Figure 3—figure supplement 1). This notion is consistent with the finding that MexB, a 
homolog of AcrB, is functional if the mexB gene is expressed in two halves, split at the N-terminal 
end of Iα (Eda et al., 2003). This construct lacks a direct link between Iα and TM6 in R1, but likely 
preserves the large interface between Iα and R2, as well as the interaction with TM2.
The membrane-domain repeats switch between an engaged and a 
disengaged state
Previous crystal structures of AcrB (Murakami et al., 2006; Seeger et al., 2006; Sennhauser et al., 
2007; Eicher et al., 2012) have revealed an intriguing network of ionic and polar side-chains in the core 
Video 1. Structural repeats within the periplasmic 
porter domain of AcrB, PN1/PC2 and PN2/PC1, and 
their collective motions during the transport cycle. L to 
T transition.
DOI: 10.7554/eLife.03145.006
Video 2. Structural repeats within the periplasmic 
porter domain of AcrB, PN1/PC2 and PN2/PC1, and 
their collective motions during the transport cycle. T to 
O transition.
DOI: 10.7554/eLife.03145.007
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of the TM domain, which seems to re-configure 
as the TM domain cycles between conforma-
tions. In particular D407 and D408 in TM4 and 
K940 in TM10 are critical for function (Guan and 
Nakae, 2001; Murakami and Yamaguchi, 2003; 
Takatsuka and Nikaido, 2006; Seeger et al., 
2009). Another functionally important side-chain, 
R971 in TM11, is located about 10 Å away from 
K940 on TM10, towards the cytoplasm.
Interestingly, all these side chains are found 
at the interface between R1 and R2, seemingly 
controlling the relative position of the repeats. 
The latest high-resolution (1.9 Å) crystal structure 
of AcrB (PDB entry 4DX5, Eicher et al., 2012), 
whose TM domain had not been previously ana-
lyzed, reveals in detail how this side-chain net-
work reorganizes throughout the conformational 
cycle (Figure 4). In both the L and T states, R1 
and R2 appear to be strongly paired through mul-
tiple interactions. First, through K940, which pro-
jects away from R2 and is sandwiched between 
D407 and D408, from R1, forming two simultaneous ionic interactions. D407 is the acceptor of an 
additional hydrogen-bond between repeats, namely from T978 in TM11. And lastly, towards the cyto-
plasm, R971 is in close proximity to E414 and N415, from TM4, particularly in the T state (Figure 4). 
(D408 is also the acceptor of an additional hydrogen-bond, but within its own repeat, namely S481 
from TM6.) In the O state, by contrast, all R1-R2 interactions break off, and are replaced by alternative 
ones within each repeat. D407 rotates to engage the backbone of G403, one helix-turn above along 
TM4; K940 retracts towards R1, and donates hydrogen-bonds to N941 (TM10) and T978; and R971 
moves away from E414/N415, and interacts instead with the backbone carbonyl of L944 and the aro-
matic ring of F948, both in TM10. (D408 also switches interaction partners, to the backbone of L442 
in TM5, i.e. also within repeat R1.) In sum, repeats R1 and R2 appear to exchange between an 
‘engaged’ state in the L and T conformations, to a ‘disengaged’ state, in the O conformation.
Proton relay across the membrane domain
To examine how the local and global changes in the structure of the TM domain of AcrB are related to 
proton translocation, we carried out two distinct but complementary computational analyses. First, we 
conducted a series of Monte Carlo simulations of the protonation equilibrium of all aspartate, gluta-
mate and histidine side-chains in the protein under a continuum-electrostatics framework, that is, via 
the Poisson equation (‘Materials and methods’). In these calculations all lysine and arginine side-chains 
were assumed to be ionized, except for K940 and R971, which were explicitly analyzed. Figure 5 sum-
marizes the results from these simulations, focusing on the TM domain. Most of the aspartate, gluta-
mate and histidine side-chains were found to be deprotonated across the LTO cycle; many of these 
aspartate and glutamate are engaged in salt-bridges, particularly on the cytoplasmic side of the pro-
tein (Figure 5A,B). A handful of residues, however, change their most probable protonation state in 
the T to O transition. These include D407 and D408, in the core of the TM domain, which are ionized 
in the L and T states but become protonated in the O state (Figure 5C). Interestingly, E346 and D924, 
at the periplasmic end of TM2 and TM10, respectively, are protonated in the L and T states, but 
become deprotonated in O; conversely, the neighboring H338 (TM2) and D566 (in the region between 
TM7 and PC1 subdomain) are most likely deprotonated in L and T, and become protonated in the O 
state (Figure 5C). Lastly, the calculations indicate that both K940 and R971 remain protonated through-
out the cycle.
As is well known, electrostatic-energy calculations based on the Poisson equation often yield diver-
gent results depending on the value of the protein dielectric constant that is assumed. Although the 
results just described are generally consistent across the range of most plausible values (Kukic et al., 
2013), namely 2 to 6, we sought to confirm our conclusions with a second methodology. In partic-
ular we used a series of all-atom molecular dynamics simulations of AcrB protomers embedded in a 
Video 3. Structural repeats within the periplasmic 
porter domain of AcrB, PN1/PC2 and PN2/PC1, and 
their collective motions during the transport cycle. O to 
L transition.
DOI: 10.7554/eLife.03145.008
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phospholipid membrane (Figure 1—figure supplement 2) to calculate the protonation free energy of 
individual sites, relative to side-chain analogs in bulk water (‘Materials and methods’). Specifically, we 
computed the free energy of protonation of D407, D408 and K940, in the O state, and of E346 and 
D924, in the T conformation. The results, shown in Figure 6, reveal strong upward shifts in the pKa of 
D407 (in the O conformation), D408(O), E346(T) and D924(T), and a weak downward shift in K940(O), 
thus confirming that these side-chains are most likely protonated in those protomer states. As controls 
we also analyzed E693(T) and K603(O), which are located on the solvent-exposed surface of the peri-
plasmic PC2 subdomain; as expected, the calculated pKa shifts for these side-chains are small or neg-
ligible (Figure 6). In sum, both all-atom molecular simulations and continuum-electrostatic calculations 
indicate that in the L and T states, two protons are bound to the TM domain of AcrB at the periplasmic 
side (i.e., D924 and E346), while D407 and D408, two-thirds of the way across the membrane, are 
deprotonated; upon transition to the O state, two protons bind to D407 and D408, while the proton-
accepting sites on the periplasmic face become deprotonated.
The proposed changes in the protonation state of D407 and D408 in the transitions from T to O 
(protonation) and O to L (deprotonation) are consistent with the ‘disengagement’ and ‘reengage-
ment’, respectively, of the structural repeats R1 and R2, as the ionic interactions with K940 would be 
weakened by protonation of the aspartate side-chains. The finding that K940 remains ionized in the 
Figure 2. Identification of structural units within the TM domain of AcrB undergoing collective motions throughout 
the LTO conformational cycle. We considered all possible combinations of 6, 5 and 4 transmembrane helices, 
within either TM1-TM6 or TM7-TM12, and compared the structure of each set of helices in the L vs T states (closed 
circles), T vs O (open circles) and O vs L (closed squares), through pairwise root-mean-square difference (RMSD) 
calculations. When these RMSD values are used as a rank, it becomes clear that combinations that exclude TM2 or 
TM8 (red) feature systematically smaller differences across the LTO cycle than those that include TM2 or TM8 
(black). All other exclusions show no clear correlation. For example, comparing TM1-TM6 (left panel) in L vs T, this 
increasing ranking is ΔTM2, ΔTM4, ΔTM1, ΔTM5, ΔTM3, and ΔTM6; in T vs O: ΔTM2, ΔTM5, ΔTM4, ΔTM3, ΔTM1, 
and ΔTM6; and in O vs L: ΔTM2, ΔTM5, ΔTM1, ΔTM4, ΔTM3, and ΔTM6. Furthermore, the data shows that 
combinations of five helices excluding TM2 and TM8 are not significantly more divergent across the LTO conform-
ers than combinations of four helices. Thus, the asymmetric crystal structure of AcrB captures collective displace-
ments of two 5-helix bundles within each protomer, formed by TM1/TM3-TM6 and TM7/TM9-TM12 (referred to as 
repeats R1 and R2), relative to flanking helices TM2 and TM8, respectively. Note that comparisons of combinations 
of seven or more helices result in larger RMSD values than those shown here, and are therefore omitted.
DOI: 10.7554/eLife.03145.009
The following figure supplements are available for figure 2:
Figure supplement 1. Structural variations in the R1 and R2 repeats of the transmembrane domain of wildtype 
AcrB, in the L, T and O states. 
DOI: 10.7554/eLife.03145.010
Figure supplement 2. Relative displacements of structural elements in the transmembrane and porter domain of 
wildtype AcrB across the LTO conformational cycle. 
DOI: 10.7554/eLife.03145.011
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O state might be less intuitive. However, analysis 
of non-redundant high-resolution structures in the 
Protein Data Bank reveals thousands of instances 
in which a lysine side-chain is part of an electro-
static interaction network that does not include 
any negatively-charged contacts (Figure 6—
figure supplement 1). Moreover, in this O state 
K940 not only hydrogen-bonds with N941 with 
T978 (Figure 4), but also interacts with water, as 
we will show below. This polar micro-environment 
explains the small shift in the pKa calculated here. 
Consistent with this result, measured pKa values 
for lysine side-chains engineered in a slightly less 
polar (and also non-ionic) environment within the 
model protein SNase are down-shifted only by 
∼2 units (Damjanović et al., 2011).
As mentioned above, experimental evidence 
demonstrates that K940 and R971 are indispen-
sable for the proton-driven mechanism of AcrB 
(Guan and Nakae, 2001; Murakami and Yamaguchi, 2003; Takatsuka and Nikaido, 2006; Seeger 
et al., 2009). Our results suggest that the primary role of these side-chains is not, however, to capture 
and donate protons; instead, they appear to function as a conformational electrostatic switch coupled 
to the protonation state of D407 and D408. In the L and T states both K940 and R971 have strong 
favorable interactions with ionized D407 and D408, which exceed their mutual repulsion (Figure 5—
figure supplement 1). Neutralization of D407 and D408, in the transition to the O state, alters this 
Figure 3. Collective motions of the structural repeats in TM domain of AcrB. For clarity, the figure shows only the transmembrane α-helices at the 
interface between repeats R1 (blue) and R2 (red), alongside the two α-helices flanking these repeats, TM2 (cyan), TM8 (orange), and the helix that links 
the two repeats, Iα (gray). Each panel depicts two conformations in the LTO cycle, overlaid optimally on TM4-TM6; thus the figure highlights the motions 
of R2 relative to R1. Initial and final states (e.g., L vs T) are shown in light and bright colors, respectively. Note that the L vs T overlay is viewed from a 
different angle than T vs O and O vs L, for clarity. Interpolations between these conformational states using the complete TM domain are shown in 
Video 4, Video 5 and Video 6.
DOI: 10.7554/eLife.03145.012
The following figure supplement is available for figure 3:
Figure supplement 1. Arrangement of helix Iα across the conformational cycle of wildtype AcrB. 
DOI: 10.7554/eLife.03145.013
Video 4. Structural repeats within the transmembrane 
domain of AcrB, R1 and R2, and their collective motions 
during the transport cycle. L to T transition.
DOI: 10.7554/eLife.03145.014
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electrostatic balance. As a result, K940 and R971 
reorient to reduce their electrostatic repulsion and 
to maximize alternative favorable interactions 
within the protein, particularly within repeat R2 
(Figure 5, Figure 5—figure supplement 1). We 
propose that the re-configuration of this reversible 
electrostatic switch, which is coupled to the pro-
tonation and deprotonation of both D407 and 
D408, is the trigger for the lateral displacements of 
repeat R2 relative to R1 observed in the T to O and 
O to L transitions (Figure 3; Video 5, Video 6).
Structures of AcrB variants are 
consistent with a two-proton 
conformational-switch mechanism
To further assess the proposed proton-relay mech-
anism and its influence on the conformation of 
the TM domain, we solved the atomic structures 
of four AcrB variants, namely K940A, R971A, 
D407N and D408N (Supplementary file 2), all of 
which abolish the drug-efflux activity of AcrB (Guan 
and Nakae, 2001; Murakami and Yamaguchi, 
2003; Takatsuka and Nikaido, 2006; Seeger 
et al., 2009). Electron-density maps for these 
variants could be resolved at resolutions ranging 
from 2.0 to 2.3 Å, which are sufficient to discern 
the precise configuration of side-chains and struc-
tural waters inside the TM domain.
In all cases, the crystal structures represent an 
asymmetric configuration of the AcrB trimer. As 
in the wildtype transporter, this asymmetry origi-
nates in the porter domain due to drug binding 
(Supplementary file 3A, Supplementary file 3B), 
compounded by the steric coupling between 
protomers in this region. This asymmetry in the 
porter domain is important for crystallization, as 
it facilitates the recognition of designed-ankyrin 
repeats proteins (DARPins) developed to improve 
wildtype crystals (Sennhauser et al., 2007). As 
in wildtype AcrB, the asymmetry of the porter domain propagates to the transmembrane region, 
where the protomers also adopt three distinct conformations.
None of the substitutions studied caused significant changes in the internal structure of the R1 and 
R2 repeats, compared to the wildtype L, T and O states (Supplementary file 3A). The relative orien-
tation of these two repeats is also unchanged in the K940A and D408N mutants (Supplementary 
file 3C), as is the side-chain configuration of the proton-relay network, aside from the mutations 
(Figure 7). That is, these two substitutions appear to perturb the conformational cycle of the trans-
porter by altering the energetic balance between the L, T and O states, rather than by precluding the 
protomers from adopting native-like conformations in each of these states. Indeed, electrostatic cal-
culations analogous to those carried out for the wildtype protein show that in the K940A structure, 
D408 is constitutively neutralized throughout the cycle. D407, which is more proximal to R971, is 
deprotonated in the L and T states and protonated in the O state, as in the wildtype (Figure 7, 
Figure 7—figure supplement 1). Similarly for the D408N variant, D407 is predicted to become pro-
tonated only in the O state, while the substituted N408 is evidently neutral throughout the cycle (K940 
and R971 are protonated in all states in both mutants) (Figure 7). These results imply that the ionic 
interactions across the R1-R2 interface that stabilize the L and T states are weakened in the mutants. 
By contrast, the O state is probably less affected (K940A) or not at all (D408N), since the repeats 
Video 5. Structural repeats within the transmembrane 
domain of AcrB, R1 and R2, and their collective motions 
during the transport cycle. T to O transition.
DOI: 10.7554/eLife.03145.015
Video 6. Structural repeats within the transmembrane 
domain of AcrB, R1 and R2, and their collective motions 
during the transport cycle. O to L transition.
DOI: 10.7554/eLife.03145.016
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become disengaged in this state. This change in the energetic balance of the conformational cycle 
(which for example would hinder the transition from O to L) would explain the drastic functional effect 
of these two mutations.
Electrostatic calculations for the R971A and D407N crystal structures indicate that, like K940A and 
D408N, these variants lack the ability to bind and release two protons (Figure 7—figure supplement 
1). In R971A, like in K940A, a first proton is already bound to the protomer in the L and T states (alter-
nating between D407 and D408, respectively) and a second proton binds in the O state (Figure 7). In 
D407N, like in D408N, only one proton is loaded (on D408), and only in the O state (Figure 7). Thus, 
also in these two variants is the key ionic interaction network at the R1-R2 interface partially neutral-
ized in the L and T states. The R971A and D407N substitutions, however, not only perturb the 
energetics of the conformational cycle and the transduction of the proton electrochemical gradient, 
but also seem to preclude the protomers from adopting all the native-like conformations, particu-
larly the T state (Figure 7). The structure of R971A shows that K940 is engaged only with D408 in 
the L state (while D407 is protonated). In the T state, K940 switches towards D407 (while D408 is 
protonated), adopting a configuration that is arguably an intermediate between the native T and 
O states: first, in that K940 retracts away from the repeat interface, unhindered by the now absent 
repulsion with R971, while still paired with D407; and second, in that as a result D407 loses its 
hydrogen bond to T978 across the R1-R2 interface. Consistent with our hypothesis that the structural 
Figure 4. Configuration of the proton-dependent conformational switch in the core of the TM domain of AcrB, in the L, T and O states, viewed from the 
periplasm. The structure corresponds to the asymmetric crystal structure of AcrB at a resolution of 1.9 Å (PDB entry 4DX5). The top panels show a close-up 
of the proton-binding sites, D407 and D408, along with neighboring side-chains, including K940 in the foreground and R971 in the background. The 
lower panels are close-ups of R971 and interacting side-chains in its proximity. The highlighted side-chains are shown along with 2Fo-Fc electron density 
maps contoured at 1.0σ. Note this proton-relay network is precisely at the interface between the two transmembrane repeats, R1 and R2 (blue and red).
DOI: 10.7554/eLife.03145.017
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configuration of the proton-relay network is intimately coupled to the displacements of the 5-helix 
repeats, the arrangement of these repeats in the T protomer of the R971A crystal structure is an inter-
mediate between the T and O states of the wildtype structure (Figure 8); in fact, this altered conforma-
tion is more similar to the latter (RMSD values of 2.4 vs 1.6 Å, respectively—Supplementary file 3C).
Figure 5. Changes in the computed protonation probability of ionizable residues in the TM domain, across the 
LTO conformational cycle. The three protomers in the asymmetric crystal structure of AcrB are shown side by side, 
in a cartoon representation (white), in the same orientation as in Figure 1. Ionizable residues are represented as 
van-der-Waals spheres, and colored according to their protonation probability, computed via Monte-Carlo 
Poisson–Boltzmann calculations (‘Materials and methods’). (A) Glu, Asp and His residues predicted to be in the 
deprotonated state in all conformations of the protomer. (B) K940 and R971 are predicted to be protonated in the 
L, T and O states; other lysine and arginine residues are assumed to be protonated in the calculation. (C) Glutamate, 
aspartate and histidine residues whose protonation state is predicted to be inter-dependent with the conformation 
of the protomer.
DOI: 10.7554/eLife.03145.018
The following figure supplement is available for figure 5:
Figure supplement 1. Electrostatic switch involving K940 and R971 upon protonation of D407 and D408. 
DOI: 10.7554/eLife.03145.019
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The effect of the D407N substitution is subtler than that of R971A, but also underscores the rela-
tionship between the local configuration of the proton-relay network and the organization of the trans-
membrane repeats. The D407N structure shows that although the substituted asparagine can accept 
a hydrogen-bond from K940 in the L and T states, its orientation is geometrically inconsistent with the 
second hydrogen-bond with T978 seen in the wildtype (Figure 7). In the L state this appears to be 
compensated by an alternative hydrogen-bond donated by N941, but this interaction is not feasible 
in the T state. In addition, the asparagine substitution removes the attractive electrostatic interaction 
between D407 with R971. In sum, the interaction network at the R1-R2 interface is partially disengaged. 
Consequently, the T state in the D407N structure shows R1 and R2 partially displaced, in a conforma-
tion that is again intermediate between the wildtype T and O states (Figure 8; Supplementary file 3C).
As mentioned above, the crystallization of these variant structures was facilitated by DARPin 
ligands, which recognize the porter domain of AcrB in its asymmetric form (Sennhauser et al., 2007; 
Eicher et al., 2012). Because the porter and transmembrane domains are necessarily coupled, it is 
conceivable that the DARPins inhibit the structural impact of the mutations, that is, only the strongest 
perturbations (R971A and D407N) would translate into noticeable structural differences in our experi-
ment. Thus, we cannot rule out that the lack of activity of these mutants reflects structural perturba-
tions more significant than those observed here. Nonetheless, even the relatively modest changes 
revealed by the structures presented here support the conclusions of our analysis of wildtype AcrB. 
That is, that there is a causal relationship between the displacements of the repeats R1 and R2 within 
the TM domain and the configuration of the proton-dependent electrostatic network at the R1-R2 
interface; that there is a conformational and electrostatic coupling between R971 and K940 and the 
two aspartate side-chains that serve as proton-binding sites; and lastly, that the transitions from T to 
O and O to L, which power the peristaltic pump mechanism of the porter domain, entail binding and 
release of two protons at D407 and D408.
Hydration of the membrane domain reveals alternating access to 
proton-relay site
Proton translocation across membrane proteins necessarily requires a pathway of water molecules to 
facilitate access from the surrounding solution, and to mediate proton hopping between protonatable 
side-chains. In the case of proton-driven secondary transporters, these pathways must also be 
Figure 6. Free energy of protonation for selected glutamate, aspartate and lysine residues in the L, T and O states. All values were computed via 
all-atom molecular simulations in a phospholipid membrane (‘Materials and methods’). Computed values for side-chain analogs in solution, whose pKa  
is known experimentally, provide a means to translate the computed free-energy values into a pKa scale (dashed lines). (A) The calculations indicate 
upward shifts in the pKa of E346 and D924 in the T state, and of D407 and D408 in the O state, relative to acetate in water, whose magnitude indicate 
that in those conformational states these residues are protonated at physiological pH. By contrast, the pKa of E693 is hardly shifted, consistent with its 
location on a water-exposed, electrostatically neutral area of the protein surface. (B) The pKa of K940 in the O state is also shifted downwards relative to 
n-butylamine in solution, on account of its being largely unexposed, but does not become deprotonated owing to polar contacts with N941 and T978 
(Figure 4).
DOI: 10.7554/eLife.03145.020
The following figure supplement is available for figure 6:
Figure supplement 1. Statistical analysis of ionic and non-ionic side-chains interactions formed by lysine side-chains in high-resolution crystal structures 
deposited in the Protein Data Bank. 
DOI: 10.7554/eLife.03145.021
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Figure 7. Configuration of the proton-binding site in asymmetric crystal structures of four AcrB variants inactive in 
drug efflux, compared to the wildtype protein. The binding site is viewed and represented as in Figure 4, omitting 
the electron-density map. The most probable protonation states of D407 and D408, based on Poisson–Boltzmann 
Figure 7. Continued on next page
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dependent on the conformational state of the protein, that is, they must be consistent with an alter-
nating-access mechanism, so as to preclude leakage and ensure strict coupling of substrate and 
proton transport. To examine whether the conformational cycle of AcrB indeed implies changes in 
proton accessibility, we carried out an all-atom molecular dynamics simulation of the complete trimer 
in a lipid membrane, and analyzed the formation and persistence of hydration channels across the TM 
domain. The results, summarized in Figure 9A, indicate that the LTO conformational cycle described 
above does indeed involve a mechanism of alternating access. More specifically, we observe that the 
L state permits the formation of two persistent water channels open to the cytoplasm, at the interface 
between repeats R1 and R2, and reaching into the proton-binding site; access from the periplasmic 
space is, however, closed (Figure 9A). In the T state, by contrast, two narrow water wires form on the 
Monte-Carlo simulations (wildtype and mutants) as well as all-atom free-energy perturbation molecular dynamics 
simulations (wildtype), are indicated in each case with ‘H+’. K940 and R971 are protonated in all cases, according to 
these calculations. Hydrogen-bonds identified on the basis of the distance and orientation of potential donors and 
acceptors, are indicated with dashed lines.
DOI: 10.7554/eLife.03145.022
The following figure supplement is available for figure 7:
Figure supplement 1. Protonation probability (%) of selected side-chains in the transmembrane domain of AcrB, in 
crystal structures of wildtype and mutagenized variants of the transporter. 
DOI: 10.7554/eLife.03145.023
Figure 7. Continued
Figure 8. Relative motions of transmembrane repeats R1 and R2 in wildtype AcrB and in the R971A and D407N 
variants, in the T to O transition. For clarity, only the three transmembrane helices at the interface between repeats 
are shown, namely TM4-TM6 (R1, blue cartoons) and TM10-TM12 (R2, red cartoons), respectively. The structural 
superimpositions shown are optimal overlays of TM4-TM6, and thus highlight the differences in the orientation of 
TM10-TM12 relative to TM4-TM6. This comparison shows that the T state in the crystal structures of the R971A and 
D407N mutants is an intermediate between the T and O conformations in wildtype AcrB. The conformation of the 
O state, however, is largely unaffected by these mutations.
DOI: 10.7554/eLife.03145.024
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Figure 9. Alternating access to the proton-binding site in AcrB. (A) Conformation-dependent water channels within 
the TM domain of AcrB, observed in all-atom simulations in a phospholipid membrane. Transmembrane helices are 
represented as cartoons and colored as in Figure 1; for clarity, TM7, TM9 and TM12 in repeat R2 are omitted. The 
locations of D407, D408, K940, R971, E346 and D924 are indicated with green spheres representing their Cα atoms. 
The water channels are represented by average density maps computed from the molecular dynamics trajectory, and 
depicted as an iso-density surface (gray). Based on this analysis, the proton-binding site is open to the cytoplasm in 
the L and O states, via two possible channels (solid black lines), whereas in the T state it is open to the periplasm, also 
via two water wires (solid black lines). A third narrow wire in the T state seems to connect the proton-binding site to 
the cytoplasm (dashed black lines), but the positively charged R971, which traverses this water wire, likely blocks H+ 
leakage. (B and C) Crystallographic water molecules (gray spheres) detected within the TM domain of AcrB, in each 
of the protomer states of the wildtype structure, as well as in the T protomer of the D407N and R971A variants.
DOI: 10.7554/eLife.03145.025
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periplasmic face of the TM domain, again reaching into the proton-binding site, and approximately 
along the interface between the two repeats R1 and R2 (Figure 9A). Interestingly, E346 and D924 flank 
the entrance of each of these water wires; as mentioned earlier, both these side-chains are likely to be 
protonated in the L and T states and deprotonated in the O state (Figure 4, Figure 5), which suggests 
that E346 and D924 facilitate proton uptake by providing transient binding sites en route to D407/
D408 (Fischer and Kandt, 2011). On the cytoplasmic side, we also observed a narrow water wire, 
flanked by R971, which is thus unlikely to sustain proton transfer, as discussed below. Finally, the O 
state features two water channels into the proton-binding site that are highly similar to those seen 
in the L conformation, that is, open to the cytoplasm, while access from the periplasmic space is 
also occluded (Figure 9A).
A striking feature of these putative access pathways for protons is that they are, for the most part, 
highly dynamic and permit individual water molecules to frequently exchange between the bulk solu-
tion and the close vicinity of the proton-binding site (Figure 10A). For the L state, for example, we 
observed more than 900 exchange events in a 250-ns period; about 70% occur via the cytoplasmic 
channel formed between helices TM5 (repeat R1) and TM10 (repeat R2), while the remainder proceeds 
via the channel formed between TM4 (R1) and TM11 (R2). Likewise for the O state, with over 600 
exchange events in the same time-period, distributed over the two channels, roughly in a 2:1 ratio. In 
the T state, the periplasmic pathway flanked by TM2-TM4 and TM11 seems to be the most dynamic, 
although much less so than the cytoplasmic channels in L and O (we observed about 30 exchange 
events), while the periplasmic wire flanked by TM10 consists of a series of water molecules that are 
static on the simulation time-scale.
As mentioned, in the T state we also observed a significant number of water molecules exchanging 
between the proton-binding site and the cytoplasm. However, the trajectories followed by these water 
molecules invariably enter or exit the TM domain in close proximity to R971 (within 10 Å) (Figure 10B). 
This positively charged side-chain very likely imposes a very large energetic barrier for proton diffusion 
to and from the cytoplasm, despite the presence of water. Such an electrostatic barrier would be anal-
ogous, for example, to that observed in the selectivity filter of aquaporins, which is also lined by an 
arginine side-chain (Kosinska Eriksson et al., 2013). By contrast, almost half of the water-permeation 
events in the L and O states involve molecular trajectories that are distant from R971 at all times 
Figure 10. Dynamic exchange of water molecules between the proton-binding site in the core of the TM domain of AcrB and the bulk solution at either 
the periplasmic or cytoplasmic sides of the membrane and proposed role of R971. (A) A random selection of single-water trajectories extracted from the 
molecular dynamics simulation are shown as blue lines, cut-off at 30 Å from the proton-binding site. The location of residues D407, D408, K940 and R971 
is indicated by their Cα atoms, shown as green spheres. Transmembrane helices in each protomer/state are represented as cartoons (white); for clarity, 
TM7, TM9 and TM12 in repeat R2 are omitted. (B) Proposed role of R971 as a selectivity filter against cytoplasmic H+ leakage in the T state of AcrB. The 
plot quantifies the frequency of water exchanges between the proton-binding site within the TM domain of AcrB and the bulk solution at the cytoplasmic 
side of the membrane, as a function of the proximity of the individual molecular trajectories to R971. In the T state, almost 100% of the water trajectories 
approach R971 within 10 Å, and therefore this water wire (dashed lines in Figure 9) is highly unlikely to sustain H+ conduction, for electrostatic reasons. In 
the L and O states, by contrast, 40% of the exchanging water molecules follow trajectories that do not approach R971 (solid lines in Figure 9).
DOI: 10.7554/eLife.03145.026
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(Figure 10B). Likewise, no large electrostatic barriers for protons are apparent along the periplasmic 
pathways in the T state.
That the hydration of the TM domain is conformationally dependent is entirely consistent with the 
electron densities from ordered water molecules in the X-ray structures of wildtype and variant AcrB. 
As shown in Figure 9B, the structure of the T state in wildtype AcrB features the abovementioned 
continuous water wire flanked by TM10, connecting the periplasmic space and D407/D408, with D924 
at its entrance. The second outward-open wire, with E346 at its entrance and running along the inter-
face between TM2-TM4 and TM11, cannot be discerned in the wildtype structure, but interestingly, 
is partially resolved in the structures of D407N and R971A (Figure 9C). As discussed earlier, in 
these crystals the T protomer is captured in an intermediate conformation between wildtype T and O, 
in which the lateral displacement of repeat R2 is already underway (Figure 8). In the native membrane 
and at room temperature, the two repeats would be much more dynamic than what appears in the 
crystal lattice, and thus we envisage that both water wires co-exist, also in the wildtype protein, as we 
observe in the simulation. In any case, it is apparent that no water wires connect the central proton-
binding site and the periplasmic space in the L and O states, in any of the structures. By contrast, a 
significant number of ordered water molecules are observed in the intracellular side of these protom-
ers. According to our simulation, the cytoplasmic channels, and particularly that between TM5 and 
TM10, are highly dynamic, and thus electron densities in this region would be poorly defined. 
Nevertheless, ordered water can be clearly discerned in the proximity of the proton-binding site, par-
ticularly in the L state (Figure 9B).
In sum, our data indicate that throughout the conformational cycle of AcrB the proton-binding 
sites within the TM domain become alternately accessible to the periplasm or the cytoplasm. As men-
tioned, this is a necessary condition in order for the transporter to harness the proton-motive-force. 
Interestingly, two distinct types of relative motion of repeats R1 and R2 result in alternating access, 
namely a rocking motion during the L to T transition, with no protons bound, and a shear motion in the 
T to O transition, in the protonated form. This finding indicates that other transporters may also follow 
significantly different conformational pathways in the substrate-bound and apo segments of their func-
tional cycle, contrary to what is often assumed. To our knowledge, however, AcrB is the only second-
ary-transporter for which two distinct structural transitions resulting in alternating access have been 
described to date.
The antiport mechanism of AcrB—conformational coupling within and 
across protomers
As described above, AcrB consists of well-defined structural elements in both its periplasmic and 
membrane domains, whose relative arrangement changes to a significant degree throughout the con-
formational cycle of the transporter. In the periplasmic domain, these rearrangements reflect sub-
strate loading from the periplasm, the re-shaping of the hydrophobic binding site, and its release into 
the TolC lumen. In the membrane domain, water pathways across the protein become reconfigured 
to facilitate access from either side of the membrane, and a network of ionic and H-bonding interac-
tions is re-organized as a result of protonation and deprotonation events.
Taken together, these observations reveal an unprecedented antiport strategy that involves the 
remote coupling of two alternating-access transport mechanisms, that is, one for drugs and another 
for protons, within each of the AcrB protomers, which we summarize in Figure 11. In the L to T transi-
tion, substrate binding in the deep binding pocket of the porter domain causes a structural change 
within the PN2/PC1 unit. This change translates into the downward displacement of TM2, which 
pushes on Iα and causes it to swing away, along with whole of the R2 repeat (Figure 3). In this transi-
tion, the interaction network formed by the proton-relay triad, D407, D408 and K940, remains engaged 
(Figure 4), with all three side-chains ionized (Figure 5, Figure 6), and seems to provide the hinge point 
of the swinging motion of R1 and R2 relative to each other (Figure 3). Importantly, this motion leads 
to alternating access of pathways for protons from either side of the membrane. Specifically, while in 
the L state the triad is accessible only from the cytoplasm, in the T state protons can only enter the TM 
domain from the periplasm (Figure 9, Figure 10). In both cases, proton transfer is highly likely to be 
mediated by water channels formed at the interface between repeats, which open or close as the 
repeats themselves rearrange relative to each other.
In the T to O transition, D407, D408 and K940 break away from each other (Figure 4), following 
binding of one proton to each of the aspartate side-chains (Figure 5, Figure 6). K940 remains in the 
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Figure 11. Proposed mechanism of drug-proton antiport in AcrB. (A) The scheme shows the conformational cycle of one of the protomers; the porter 
domain is viewed from the outer membrane, and the TM domain is viewed along the membrane plane. The structural repeats in the TM and porter 
domains, R1 and R2, and PC1/PN2 and PN1/PC2, respectively, are colored as in Figure 1. Likewise for the TM2 and TM8, which flank R1 and R2 and 
couple them to the repeats in the porter domain. The conformational state (L/T/O) of each protomer is indicated alongside the proposed location of the 
substrate (D) and the protons (H+) in each state. Residues in the proton relay network formed by K940, R971, D407 and D408, which controls the relative 
orientation of R1 and R2, are indicated with ‘+’ and ‘−’ symbols. The series of states proposed for the TM domain is based on the analysis of protonation 
states and water accessibility of wildtype AcrB and its variants, reported above. The model postulates that TM2 and TM8 mediate the strict coupling 
between these two conformational cycles. (B) The scheme shows the conformational cycle of the porter-domain trimer, viewed from the outer-membrane. 
The specific series of states proposed for the porter domain derives from analysis of potential steric clashes at the protomer–protomer interface in all 
possible combinations of L, T and O conformations (Figure 11—figure supplement 1). Note that the frequency of protomers in the O state is mini-
mized, relative to other possible cycles, while that of protomers in the L and T state is maximized; we propose this kinetically advantageous, in that it 
would result in minimum back-flow of substrates from the exit pore, and maximal capture from the periplasmic space.
DOI: 10.7554/eLife.03145.027
The following figure supplement is available for figure 11:
Figure supplement 1. Mechanistic significance of the conformational coupling among protomers. 
DOI: 10.7554/eLife.03145.028
ionized, protonated state, and retracts towards TM10/TM11 to compensate for the loss of interaction 
partners. R971 (on TM11) also reconfigures in response to these events, rotating towards TM10. As a 
result, the repeats R1 and R2 become disengaged, and R2 (along with Iα) moves laterally relative to R1 
(Figure 3). This displacement allows TM2 to return to the up conformation, and importantly, enables 
TM8 to come into close proximity to R2. The displacement of TM8 causes the PN1/PC2 repeat in the 
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porter domain to move, as a rigid body, against PN2/PC1, thus closing the binding cleft to the peri-
plasmic space, and triggers instead the opening of an exit pathway towards the funnel domain. The 
ability of TM8 to steer the motion of PN1/PC2 in the T to O step (Video 5) seems to be facilitated 
by the elongation of the helical fold of TM8, on the periplasmic side, upon transition from L to T 
(Video 4); this naturally facilitates its coupling to the motion of PN1/PC2. Crucially, in the O state the 
proton-relay site is again accessible to the cytoplasm, and not to the periplasm (Figure 9, Figure 10). 
Thus, deprotonation will imply a release of the bound protons down the electrochemical gradient. 
Proton release into the cell interior also causes the R1 and R2 repeats to re-engage (Figure 4), and thus 
the dissociation of TM8 from R2 when reforming the L state (Figure 3). This enables the re-opening 
of the drug-binding cleft between PC1 and PC2, exposing the access binding pocket (Nakashima 
et al., 2011; Eicher et al., 2012) to the periplasm, ready to sequester a new drug molecule.
It is worth noting that the directionality of this mechanism is entirely encoded structurally, for each 
of the protomers. Proton uptake leads to substrate export (instead of symport) for two reasons: first, 
both proton- and substrate-binding sites are concurrently open to the periplasm in the T state, while 
in the O state they become open to the cytoplasm and the TolC lumen, respectively; second, both 
porter and membrane domains are able to re-open to the periplasm after releasing their cargo, that 
is, in their apo state (Figure 11A, drug access pocket and proton loading). Thus, the free-energy gain 
associated with downhill proton permeation compensates the cost of uphill efflux of cytotoxic com-
pounds. This energy-transduction process is reminiscent of the binding-change mechanism of the 
F1Fo-ATP synthase, which also utilizes the energy harnessed from the transmembrane electrochemical 
proton gradient to release synthesized ATP molecules from their binding sites in the α/β subunits 
(Boyer, 1997; Pos, 2009).
Although the mechanism and energetics of transport in AcrB can be fully rationalized in terms of 
the individual protomers, the extensive trimer interface within the porter domain suggests that the 
protomers are conformationally coupled. Indeed, transport of certain cephalosporins and penicillins 
has been shown to be highly cooperative (Nagano and Nikaido, 2009; Lim and Nikaido, 2010). How 
the cross-talk among protomers might benefit the antiport mechanism is, however, not immediately 
evident. From an architectural standpoint, trimerization is necessary for AcrB to form a pore leading 
into the TolC channel, but why would the protomers not cycle independently from each other? A dis-
advantage of independent protomer cycling would be that a drug released into the exit pore by a 
protomer in the O state would often be exposed to a second protomer also in the O state, which 
would enhance the probability of re-binding. Such event would not likely result in drug re-uptake 
(which would require uphill proton transport) but efflux would be surely hindered from a kinetic stand-
point, because the drug concentration within TolC is probably very large. Ideally, therefore, the number 
of trimer configurations in which one or more protomer are in the O state ought to be somehow mini-
mized. Following the same kinetic argument, it would be advantageous if AcrB maximizes the number 
of trimer configurations featuring the L and T states in one or more protomers, so as to accelerate 
capture (or re-capture) of the substrate from the periplasmic space or the inner membrane.
Remarkably, analysis of computer-generated models of the porter domain in all non-symmetric 
permutations of the L, T and O states (‘Materials and methods’) indicates that this kind of kinetic 
optimization is what emerges from the conformational coupling among protomers. A quantifica-
tion of the steric clashes between protomers in these hypothetical models indicates that OO and 
LO interfaces (counter-clockwise, viewed from TolC) are highly incompatible, and that OT is also 
suboptimal. Thus, most of the combinations that include one or more O states in the trimer would 
be energetically unfeasible (Figure 11—figure supplement 1). Figure 11 depicts the conforma-
tional cycle of the porter domain that involves only the most plausible combinations, alongside 
the cycle of the TM domain described earlier. Throughout this cycle, the proportion of protomers 
in either the L or T state relative to those in the O state is fourfold greater than in a hypothetical 
uncoupled trimer (Figure 11—figure supplement 1). That is, the AcrB protomers are substantially 
more efficient efflux pumps if they are coupled; not because the protomers energize each other, 
but because collectively they are able to restrict their conformational pathways so as to achieve 
the most productive mechanism.
Conclusions
New high-resolution crystal structures of wildtype and AcrB variants, systematically analyzed through 
diverse computational methods, have enabled us to formulate a novel, clear-cut theory of the 
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mechanism of proton-coupled drug-efflux in this very complex transport system. On the basis of 
this theory, which is consistent with existing biochemical, structural and functional data, additional 
and more precise experiments and computations may now be designed to further establish the pro-
posed molecular mechanism of transport and energy transduction. It will also be of interest to extrap-
olate these findings to other homologues in the RND superfamily. Such investigations could potentially 
aid the development of novel pharmacological approaches, such as conformational inhibitors, against 
Gram-negative multidrug resistant pathogens.
Materials and methods
Bacterial strains, plasmids and growth conditions
E. coli C43 (DE3) (Miroux and Walker, 1996) harboring mutant derivatives of pET24acrBHis (Pos 
and Diederichs, 2002; Seeger et al., 2009) were used for protein overexpression. LB medium and 
LB agar (Sambrook et al., 1989) were used for routine bacterial growth at 37°C. Terrific broth 
(Tartoff and Hobbs, 1987) was used for protein overexpression. Kanamycin (Applichem, Germany) 
was applied at 50 μg ml−1 (Kan50).
Crystallization of variant AcrB in complex with DARPins
Overexpression and membrane preparation of wildtype and mutant AcrB was carried out as described 
previously (Pos and Diederichs, 2002; Seeger et al., 2006). DARPin clone 1108_19 (Sennhauser 
et al., 2007) was overexpressed and purified according to Binz et al. (2003). To crystallize the AcrB/
DARPin complex, the method described by Sennhauser et al. (2007)with n-dodecyl-β-D-maltoside 
as detergent (Glycon Biochemicals, Germany) was applied. For all AcrB variants except R971A, mino-
cycline was added prior to crystallization at a concentration of 2 mM (Sigma-Aldrich, Germany). All 
crystals were grown by the hanging drop vapor diffusion method at 0.05 M ADA buffer pH 6.5, 7–9% 
polyethylene glycol (PEG) 4000, 6–10% glycerol, 0.2 M (NH4)SO4. Cryprotection was achieved by 
transfer of the crystals to the same buffer containing 30% glycerol and flash freezing into liquid N2.
X-ray diffraction dataset analysis and refinement procedure
Datasets of P212121 crystals were collected at beamline X06SA (wavelength 0.8–1.0 Å) of the Swiss 
Light Source (Paul Scherrer Institut, Villigen, Switzerland). Data reduction was done with the XDS 
package (Kabsch, 2010). The structures were solved by molecular replacement using MOLREP (Vagin 
and Teplyakov, 2010) or PHASER (McCoy et al., 2007). As search model pdb entry 4DX5 (Eicher 
et al., 2012) was used and model rebuilding was employed using COOT (Emsley et al., 2010). 
Refinement was carried out with PHENIX (Adams et al., 2010) and REFMAC5 (Murshudov et al., 
2011) and additional water molecules appended. Model rebuilding and water molecule analysis 
was done employing COOT (Emsley et al., 2010). Figures were created using PyMOL (The PyMOL 
Molecular Graphics System, Version 1.5.0.3 Schrödinger LLC, Oregon, USA).
Calculation of protonation probabilities
Protonation probabilities were calculated using two independent methodologies. Wildtype and 
mutagenized AcrB structures were analyzed via Monte-Carlo/Poisson-equation simulations of the 
global protonation equilibrium in the complete trimer. In addition, selected ionizable side-chains in the 
wildtype transporter were analyzed via all-atom molecular dynamics simulations of individual protom-
ers, using the free-energy perturbation (FEP) method. To assess the most likely protonation state of 
the ionizable side-chains in AcrB, we carried out a series of Metropolis Monte-Carlo simulations of the 
global protonation equilibrium of the protein at fixed pH. In a first set of calculations, we analyzed in 
each protomer separately, including all ionizable side-chains in the calculation. All lysine and arginine 
side-chains were consistently predicted to be protonated at the pH and dielectric constant values used 
in these calculations (see below). Thus, in subsequent simulations, in which the complete trimer was 
considered, all lysine and arginine side-chains were fixed in their ionized state, except for K940 and 
R971, which were explicitly re-analyzed along with all aspartate, histidine and glutamate residues 
(306 side-chains in total).
Each Monte Carlo simulation was initiated with a random configuration of protonation states, and 
consists of five cycles of temperature annealing and a subsequent equilibration. In the annealing phases, 
the temperature was raised to 400 K and then gradually reduced to 300 K over 100,000 simulation 
steps. The equilibration phases, in which the temperature was kept at 300 K, lasted 500,000 steps. The 
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protonation probability of each group was determined by averaging the ionisation states sampled during 
the equilibration phase of the final cycle of the simulation. This procedure was repeated 10 times with 
independent starting configurations, resulting in a global average; the typical statistical error was <2%.
To evaluate the energy changes associated with the Monte Carlo moves we used a continuum elec-
trostatic model, that is, the crystal structure of the AcrB trimer is surrounded by a high-dielectric 
medium representing water, except for a low-dielectric rectangular slab surrounding the transmem-
brane domain, which mimics the lipid membrane. Specifically, we used the linearized Poisson-
Boltzmann equation solver implemented in CHARMM c34a2 (Brooks et al., 2009) to set up the 
continuum model and to compute all the necessary electrostatic energy contributions. In all simula-
tions the dielectric constant of the solvent was 80, and that of the membrane was 2. The results 
described in the manuscript and represented in Figure 5 and Figure 6 correspond to a protein dielec-
tric constant of 4; alternative values ranging from 2 to 6 were also explored, which resulted in analo-
gous conclusions (not shown). The atomic charges employed are those in the CHARMM27 force field 
(MacKerell et al., 1998). The atomic radii are those previously optimized for continuum electrostatic 
calculations based on the CHARMM27 force field (Nina et al., 1997). Non-standard radii were adapted 
according to chemical similarity, for example, the radius of the Nζ atom in the neutral lysine was con-
sidered to be equal to that of the side-chain nitrogen atom of asparagine/glutamine.
The reference aqueous-phase pKa values were: aspartate, 4.0; glutamate, 4.4, histidine, 6.3; lysine, 
10.4; and arginine, 12.0. Residues on the periplasmic side of the protein were assumed to exchange 
protons with a solution at pHout = 5.5, while those on the cytoplasmic side exchanged with a solution 
at pHin = 7.5; interpolated pH values in this range were used for residues across the membrane. 
Calculations with an alternative value of pHout = pHin = 7.5 led to analogous conclusions (not shown).
Molecular dynamics simulations
All molecular dynamics simulations were carried out at 298 K and 1 atm. Three independent all-
atom systems were studied, namely the complete asymmetric AcrB trimer and truncated constructs of 
the T and O protomers comprising the transmembrane and porter domains only (Figure 1—figure 
supplement 2). In all cases the protein structures were embedded in a hydrated POPC bilayer using 
GRIFFIN (Staritzbichler et al., 2011). All simulations were initiated with the high-resolution (1.9 Å) 
crystal structure of wildtype AcrB (PDB entry 4DX5). The simulation system for the complete AcrB 
trimer includes ∼369,000 atoms, enclosed in a periodic orthorhombic box of dimensions ∼150 × 150 × 
160 Å. This system was simulated for 250 ns (after equilibration) to assess the formation and dynamics 
of water channels within the transmembrane domain. The protomer systems include ∼101,000 atoms 
in a periodic orthorhombic box of dimensions ∼90 × 90 × 120 Å. These systems were used to evaluate 
the most likely protonation state of selected side-chains using the FEP method. Each of these calcula-
tions entailed a total of ∼80 ns of simulation (after equilibration). Three independent all-atom simula-
tion systems were studied, namely the complete asymmetric AcrB trimer (residues 1 to 1044 in each 
protomer) (Figure 1—figure supplement 2); a truncated constructs of the T protomer, comprising the 
transmembrane and porter domains only (residues 1 to 182, 275 to 723 and 813 to 1044) (Figure 1—
figure supplement 2); and an analogous truncated construct of the O protomer. In all cases the 
protein structures were embedded in a hydrated phospholipid (POPC) bilayer using the GRIFFIN 
method (Staritzbichler et al., 2011), adding Na+ counter ions when necessary to neutralize the total 
charge of the system.
This system was employed to assess the formation and dynamics of water channels within the 
transmembrane domain. A minocycline molecule was bound to the porter domain in the T protomer. 
D407 and D408 were deprotonated in the L and T protomers, and protonated in the O protomer; 
K940 and R971 were protonated in all protomers. The simulation was initiated with the high-resolution 
(1.9 Å) crystal structure of wildtype AcrB (PDB entry 4DX5), preserving crystallographic water mol-
ecules. Additional water molecules within the protein structure were placed with DOWSER (http://
danger.med.unc.edu/hermans/dowser/dowser.htm). To optimize the protein-solvent and protein-
lipid interfaces in the model, and to thermalize the system, a series of short simulations (10 ns) 
were initially carried out with gradually weaker positional restraints applied to the protein and the 
crystallographic and DOWSER-added water molecules (excluding hydrogen atoms). To enable the 
protein to tumble, the equilibration phase was extended (5 ns) after replacing the positional 
restraints with collective conformational restraints (RMSD), applied first to the whole protein, and 
subsequently to each of three transmembrane domains separately. In the last state of the equilibration 
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(10 ns), only the configuration of the proton-relay network was preserved via inter-residue distance 
restraints (flat-bottom harmonic potential). Finally, a fully unrestrained simulation was carried out 
for 250 ns.
The truncated-protomer systems were used to re-evaluate the most likely protonation state of 
selected side-chains using the free-energy perturbation (FEP) method; the substantial computational 
cost of this methodology is what motivated the truncation of the protein. The preparation and equili-
bration of these reduced simulation systems was analogous to the procedure followed for the trimer. 
In the final production phase (90 ns), however, only the transmembrane domain was fully unrestrained. 
The conformation of the porter domain was preserved using a harmonic restraint on its RMSD relative 
to the crystal structure, to preclude any distortions resulting from the artefactual truncation of the 
funnel domain. Importantly, the force constant of this harmonic restraint was selected so that the struc-
tural fluctuations of the porter domain in the truncated-protomer system are comparable to those 
observed in the unrestrained simulations of the complete trimer (not shown). Thus, the dynamics of the 
transmembrane domain during the free-energy calculations is unlikely to be significantly affected by 
the truncation. For both T and O protomers, snapshots after 90 ns of simulation were extracted and 
used to initiate the FEP calculations. Here, the protonation state of a given side-chain is exchanged 
alchemically, using a step-wise protocol controlled by a parameter λ that reflects the weight of either 
protonation state in the potential energy function of the system. All FEP calculations were carried out 
in the forward and backward directions, with 38 intermediate λ steps (33 for D408 in the O state). The 
simulation time per λ step was 1 ns; the initial 100 ps of each simulation were considered as equilibra-
tion, and so free-energy increments were obtained from the final 900 ps.
All molecular dynamics simulations were carried out with NAMD 2.7 (Phillips et al., 2005), using an 
integration time-step of 2 fs, periodic boundary conditions, and a Langevin thermostat set to 298 K. 
The pressure along the direction perpendicular to the membrane was maintained at 1 atm using a 
Nose-Hoover Langevin piston, while keeping the surface area of the membrane constant (∼69 Å2 per 
lipid). Electrostatic interactions were calculated using the Particle-Mesh-Ewald algorithm, with a real-
space cut-off of 12 Å. A shifted Lennard-Jones potential, also cut-off at 12 Å, was used to compute 
van-der-Waals interactions. The CHARMM27/CMAP force field for proteins and lipids (MacKerell 
et al., 1998, 2004) was used in all calculations. Force field parameters for minocycline were taken 
from Aleksandrov and Simonson (2009). Water density maps were calculated with VMD (Humphrey 
et al., 1996).
Statistical analysis of lysine interactions in the PDB
The frequency of hydrogen-bonded interaction networks involving lysine side-chains and other 
polar and/or acidic residues was quantified using a subset of entries in the Protein Data Bank that 
consists of all protein X-ray structures of resolution 3.0 Å or better, excluding redundant entries with 
sequence identity greater than either 30% or 70%. A distance threshold of 3.0 Å was used to identify 
hydrogen-bonds donated by lysine Nζ atoms to potential acceptor oxygen atoms in either Asp (Oδ), 
Asn (Oδ), Glu (Oε), Gln (Oε), Ser (Oγ) or Thr (Oγ) side-chains.
Steric exclusions in the conformational cycle of the porter domain
Alternative structures of the porter domain were modeled in all possible permutations of the L, T and 
O conformations, via rigid-body rotations of the PC1/PN2 and PN1/PC2 sub-domains around the 
trimer axis. All side-chains in all models (including the crystallographic LTO state) were then re-built 
using SCWRL4 (Krivov et al., 2009). The solvent-excluded surface (probe radius of 1.4 Å) of each 
protomer in each model was then calculated with MSMS (Sanner et al., 1996), and mapped onto a 
fine cubic grid. The overlap volume at each of the three promoter interfaces was computed by counting 
the number of grid-points concurrently inside two opposing surfaces. The models were ranked 
according to the total value of the overlapping volume.
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